Our experience in the treatment of hemangiomas using maxillofacial β-adrenoblockers in children

To date, a number of complex treatment methods are most often used to treat this pathology. It is worth emphasizing that despite the variety of therapy methods, none of them can be discredited in favor of the other, since each has its own "resolving power". Despite the numerous approaches to the treatment of this pathology, there is currently no universal method of treating hemangiomas in children, none of the existing methods allows achieving a one-time radical treatment result. Thus, the variety of existing methods of treating hemangiomas, the emergence of new conservative and surgical treatment options indicate the difficulty of choosing this pathology. This indicates the relevance of research in this area. And also one side of the urgency of this problem is represented by developments on a combination of improved (improving cosmetic and functional results, as well as accelerating healing) and traditional methods of therapy, that is, to change treatment tactics. The achievements of technological progress stimulate the development of new types of therapeutic effects - low temperatures, ultrahigh-frequency electromagnetic fields, ultrasound, laser radiation, and so on. However, to date, there is no universal method of treating infant hemangiomas, in each case it is necessary to make a choice in favor of one of the methods or a combination of them. Despite the variety of treatment options, all of them alon. The article presents all possible ways to improve the diagnosis, the use of b-blockers in the treatment of hemangiomas of the external integument in children.